133008-08-9

Basic information

• Product Name: (R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL
• Synonyms: 1,3-DIOXOLANE-4-PROPANOL, 2,2-DIMETHYL-, (R)-;(R)-4,5-ISOPROPYLIDENE-1-PENTANOL;(R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL;(4R)-2 2-DIMETHYL-1 3-DIOXOLANE-4-PROPA&;(4R)-2,2-Dimethyl-1,3-dioxolane-4-(3-propanol);(4R)-2,2-Dimethyl-1,3-dioxolane-4-propanol
• CAS NO: 133008-08-9
• Molecular Formula: C₈H₁₆O₃
• Molecular Weight: 160.21
• Mol File: 133008-08-9.mol

Chemical Properties

• Boiling Point: 221.017 °C at 760 mmHg
• Flash Point: 103.746 °C
• Appearance: /
• Density: 0.996 g/cm³
• Vapor Pressure: 0.023mmHg at 25°C
• Refractive Index: 1.434
• CAS DataBase Reference: (R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL(133008-08-9)
• EPA Substance Registry System: (R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL(133008-08-9)

Safety Data

• Hazard Codes: Xi
• Statements: 37/38-41-43
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 133008-08-9(Hazardous Substances Data)

Usage

Uses

Used in Chemical Industry:
(R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL is used as a solvent for various industrial applications, leveraging its ability to dissolve a wide range of substances and facilitate chemical reactions.
Used in Pharmaceutical Industry:
(R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL is used as a chiral resolving agent in organic synthesis, playing a crucial role in the production of enantiomerically pure compounds, which are essential for the development of many pharmaceutical drugs.
Used in Research and Development:
(R)-2,2-DIMETHYL-1,3-DIOXOLANE-4-PROPANOL is employed in research settings for the study of its interactions with organic molecules, potentially leading to new discoveries and applications in the fields of chemistry and materials science.

InChI:InChI=1/C8H16O3/c1-8(2)10-6-7(11-8)4-3-5-9/h7,9H,3-6H2,1-2H3/t7-/m1/s1

Upstream product

• 19131-21-6 (2S)-pentane-1,2,5-triol 
• 67-64-1 acetone 
• 917877-01-1 R-3-(2,2-dimethyl[1,3]dioxolan-4-yl)-acrylic acid ethyl ester 
• 14347-78-5 1,2-O-isopropylidene-D-glycerol 
• 21461-84-7 (2S)-tetrahydro-5-oxofuran-2-carboxylic acid 
• 77-76-9 2,2-dimethoxy-propane 
• 171335-70-9 (2R)-pentane-1,2,5-triol 
• 22323-80-4 (4S)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde 
• 36326-38-2 ethyl (E)-3-[(R)-2,2-dimethyl-1,3-dioxolan-4-yl]acrylate 
• 36326-38-2 ethyl (R,Z)-3-(2′,2′-dimethyl-1′,3′-dioxolan-4′-yl)acrylate 
• 133494-69-6 (R)-4-but-3-enyl-2,2-dimethyl[1,3]dioxolane 
• 173152-84-6 ethyl (R)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)propionate 

Downstream Products

• 267011-41-6 (R)-5-tert-butyldiphenylsilyloxy-2-methoxymethoxypentan-1-ol 
• 267011-42-7 (R)-5-tert-butyldiphenylsilyloxy-1-iodo-2-methoxymethoxypentane 
• 267011-40-5 (R)-5-tert-butyldiphenylsilyloxypentane-1,2-diol 
• 251998-87-5 (1''R,2'R,5'R,2R,6RS)-2,6-dihydroxy-6-(5'-(1''-(methoxymethoxy)tridecyl)tetrahydrofuran-2'-yl)hexyl 2,4,6-triisopropylbenzenesulfonate 
• 251998-93-3 (R)-2-hydroxy-7-trimethylsilyl-6-heptynyl 2,4,6-triisopropylbenzenesulfonate 
• 851532-62-2 (2R,5R)-trans-5-((4-fluorophenoxy)methyl)-2-(1-[N,O-bis(phenoxycarbonyl)hydroxylamino]-3-butyn-4-yl)tetrahydrofuran 
• 851532-63-3 (2S,5R)-cis-5-((4-fluorophenoxy)methyl)-2-(1-[N,O-bis(phenoxycarbonyl)hydroxylamino]-3-butyn-4-yl)tetrahydrofuran 
• 254891-81-1 (2S)-5-acetoxy-2-hydroxy-9-(4-methoxybenzyloxy)-1-(p-toluenesulfonyloxy)non-6-yne 
• 851532-56-4 (2R)-5-acetoxy-2-hydroxy-9-(4-methoxybenzyloxy)-1-(p-toluenesulfonyloxy)non-6-yne 
• 851532-58-6 (2R)-5-[1-(4-methoxybenzyloxy)-3-butyn-4-yl]-2-(p-toluenesulfonyloxy)tetrahydrofuran 
• 254891-82-2 (2S)-5-[1-(4-methoxybenzyloxy)-3-butyn-4-yl]-2-(p-toluenesulfonyloxy)tetrahydrofuran 
• 851532-59-7 (5R)-5-((4-fluorophenoxy)methyl)-2-[1-(4-methoxybenzyloxy)-3-butyn-4-yl]tetrahydrofuran 
• 254891-83-3 (5S)-5-((4-fluorophenoxy)methyl)-2-[1-(4-methoxybenzyloxy)-3-butyn-4-yl]tetrahydrofuran 
• 851532-54-2 (2R)-5-acetoxy-1,2-(isopropylidenedioxy)-9-(4-methoxybenzyloxy)non-6-yne 

Relevant articles and documents

Reductive spiroannulation of nitriles with secondary electrophiles

(Chemical Equation Presented) The scope of reductive decyanation and spiroannulation reactions has been expanded to include secondary electrophiles for potentially useful transformations. Secondary phosphates and chlorides, as well as terminal epoxides, c

MONOBACTAM COMPOUNDS AND USE THEREFOR

Monobactam compounds and a use therefor. Specifically provided are chemical compounds represented by formula (I) or isomers, pharmaceutically acceptable salts, solvates, crystals, or prodrugs thereof, preparation methods therefor, pharmaceutical compositions containing said compounds, and a use of said compounds or compositions in treating bacterial infection. The present compounds feature excellent antibacterial activity, and have great hopes of becoming a therapeutic agent for bacterial infection.

One-pot, two-step synthesis of unnatural α-amino acids involving the exhaustive aerobic oxidation of 1,2-diols

Herein, we report the nor-AZADO-catalyzed exhaustive aerobic oxidations of 1,2-diols to α-keto acids. Combining oxidation with transamination using dl-2-phenylglycine led to the synthesis of free α-amino acids (AAs) in one pot. This method enables the rapid and flexible preparation of a variety of valuable unnatural AAs, such as fluorescent AAs, photoactivatable AAs, and other functional AAs for bioorthogonal reactions.

ANGIOTENSIN II RECEPTOR ANTAGONISTS

A compound having the structure (Formula I), wherein R is an angiotensin receptor antagonist active group, Y is -Y1-Y2-Y3-Y4-Y5.; Y1 is C(R1R2); R1 is selected from the group consisting of hydrogen and C1-4 alkyl; R2 is selected from the group consisting of hydrogen, C1-4 alkyl, and -0C(0)C1-4 alkyl; Y2 is O or CH2; Y3 is C(O) or CH2; Y4 is O or CH2; Y5 is -(CH2) 1-2-(X)0-l-(CH2)0-l- or is absent; X is -O- or - CR3R4-; and R3 and R4 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.

Unified total synthesis of pteriatoxins and their diastereomers

A unified total synthesis is reported to access all of the possible diastereomers of pteriatoxins A-C, with the use of an intramolecular Diels-Alder reaction as the key step to form the carbo-macrocyclic core structure. The C34/C35-diol protecting groups were found to have significant effects on both the exo/endo-selectivity and the exo-facial selectivity of the intramolecular Diels-Alder process. Copyright

Stereoselective synthesis of chiral tetrahydrofurans with potent 5-LO inhibitory activity

Chiral glyceraldehydes have been exploited for the design of convenient and scalable synthetic approaches to chiral tetrahydrofurans, which have potential as potent 5-lipoxygenase (5-LO) inhibitors. The synthesis of all four possible stereoisomers by a general methodology is reported; wherein the chirons derived from the glyceraldehyde derivatives on reaction with homopropargyl ether, cyclization and further reactions gave the targets.

Stereoselective syntheses of pharmaceutically relevant chiral tetrahydrofurans from (S)- and (R)-glyceraldehyde derivatives

A practically simple and flexible method of making chiral tetrahydrofurans of therapeutic relevance is reported from glyceraldehyde derivatives as chiral synthons. One of the stereocentres is derived from glyceraldehyde derivatives, while the other one is introduced by Sharpless asymmetric epoxidation using either (+)- or (-)-DIPT.

Synthesis of the spiroacetal fragment of broussonetine H

(2S,6S)-2-(3-Bromopropyl)-1,7-dioxaspiro[5.5]undecane 3 was prepared by the addition of the acetylide derived from (4S)-4-benzyloxy-7-tert-butyldiphenylsilyloxyhep-1-yne 8 to δ-valerolactone 6 followed by treatment with hydrogen and palladium on charcoal which effected hydrogenation of the alkyne, hydrogenolysis of the benzyl ether and subsequent spiroacetal formation. The (4S)-stereochemistry in acetylene 8 was established by addition of trimethylsilylacetylene 10 to (2S)-epoxide 9, which in turn is derived from L-glutamic acid 11.